Clinical Study
Analysis of Safety from a Human Clinical Trial with Pterostilbene
Table 2
Self-reported adverse drug reactions (ADRs)a.
| | | ADRs reported (%) | value (versus placebo) | Type of ADR (#) |
| Any pterostilbene | 60 | 10 (16.7) | 0.72 | — |
| High-dose pterostilbene | 20 | 5 (25) | 0.42 | Gastrointestinal (2) Increased appetite (2) Itching (1) | Low-dose pterostilbene | 20 | 3 (15) | 1.00 | Muscle pain (2) Increased appetite (1) | Low-dose + grape extract | 20 | 2 (10) | 1.00 | Muscle pain (1) Increased appetite (1) |
| Placebo | 20 | 2 (10) | — | Gastrointestinal (1) Itching (1) |
|
|
aIntention-to-treat population evaluated.
|